Inflammation in new-onset atrial fibrillation after cardiac surgery: A systematic review

European Journal of Clinical Investigation

Volumn 44, Issue 4, 2014, Pages 402-428

  Jacob, Kirolos A ^a   Nathoe, Hendrik M ^a   Dieleman, Jan M ^a   Van Osch, Dirk ^a   Kluin, Jolanda ^a   van Dijk, Diederik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anti inflammatory drugs; Cardiac surgery; Inflammation; Inflammatory biomarkers; Postoperative new onset atrial fibrillation

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; COLCHICINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID; VITAMIN;

CARDIOVASCULAR INFLAMMATION; DISEASE ASSOCIATION; HEART ATRIUM FIBRILLATION; HEART SURGERY; HUMAN; LEUKOCYTE COUNT; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE NEW ONSET ATRIAL FIBRILLATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEROID THERAPY; SURGICAL RISK; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY DRUGS; CARDIAC SURGERY; INFLAMMATION; INFLAMMATORY BIOMARKERS; POSTOPERATIVE NEW-ONSET ATRIAL FIBRILLATION;

ACETYLCYSTEINE; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; COLCHICINE; EPIDEMIOLOGIC METHODS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; POSTOPERATIVE COMPLICATIONS; STEROIDS; VITAMINS;

EID: 84895917849     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12237     Document Type: Review

References (70)

1. Mathew JP, Fontes ML, Tudor IC, Ramsay J, Duke P, Mazer CD et al. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA 2004;291:1720-9.
2. Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008;51:793-801.
3. Gasparovic H, Burcar I, Kopjar T, Vojkovic J, Gabelica R, Biocina B et al. NT-pro-BNP, but not C-reactive protein, is predictive of atrial fibrillation in patients undergoing coronary artery bypass surgery. Eur J Cardiothorac Surg 2010;37:100-5.
4. Kinoshita T, Asai T, Takashima N, Hosoba S, Suzuki T, Kambara A et al. Preoperative C-reactive protein and atrial fibrillation after off-pump coronary bypass surgery. Eur J Cardiothorac Surg 2011;40:1298-303.
5. Choi YS, Shim JK, Hong SW, Kim DH, Kim JC, Kwak YL. Risk factors of atrial fibrillation following off-pump coronary artery bypass graft surgery: predictive value of C-reactive protein and transfusion requirement. Eur J Cardiothorac Surg 2009;36:838-43.
6. Fontes ML, Amar D, Kulak A, Koval K, Zhang H, Shi W et al. Increased preoperative white blood cell count predicts postoperative atrial fibrillation after coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2009;23:484-7.
7. Girerd N, Pibarot P, Fournier D, Daleau P, Voisine P, O'Hara G et al. Middle-aged men with increased waist circumference and elevated C-reactive protein level are at higher risk for postoperative atrial fibrillation following coronary artery bypass grafting surgery. Eur Heart J 2009;30:1270-8.
8. Sezai A, Hata M, Niino T, Kasamaki Y, Nakai T, Hirayama A et al. Study of the factors related to atrial fibrillation after coronary artery bypass grafting: a search for a marker to predict the occurrence of atrial fibrillation before surgical intervention. J Thorac Cardiovasc Surg 2009;137:895-900.
9. Canbaz S, Erbas H, Huseyin S, Duran E. The role of inflammation in atrial fibrillation following open heart surgery. J Int Med Res 2008;36:1070-6.
10. Ucar HI, Tok M, Atalar E, Dogan OF, Oc M, Farsak B et al. Predictive significance of plasma levels of interleukin-6 and high-sensitivity C-reactive protein in atrial fibrillation after coronary artery bypass surgery. Heart Surg Forum 2007;10:E131-5.
11. Ahlsson AJ, Bodin L, Lundblad OH, Englund AG. Postoperative atrial fibrillation is not correlated to C-reactive protein. Ann Thorac Surg 2007;83:1332-7.
12. Hogue CW Jr, Palin CA, Kailasam R, Lawton JS, Nassief A, Dávila-Román VG et al. C-reactive protein levels and atrial fibrillation after cardiac surgery in women. Ann Thorac Surg 2006;82:97-102.
13. Lo B, Fijnheer R, Nierich AP, Bruins P, Kalkman CJ. C-reactive protein is a risk indicator for atrial fibrillation after myocardial revascularization. Ann Thorac Surg 2005;79:1530-5.
14. Pretorius M, Donahue BS, Yu C, Greelish JP, Roden DM, Brown NJ. Plasminogen activator inhibitor-1 as a predictor of postoperative atrial fibrillation after cardiopulmonary bypass. Circulation 2007;116(11 Suppl):I1-7.
15. Skuladottir GV, Heidarsdottir R, Arnar DO, Torfason B, Edvardsson V, Gottskalksson G et al. Plasma n-3 and n-6 fatty acids and the incidence of atrial fibrillation following coronary artery bypass graft surgery. Eur J Clin Invest 2011;41:995-1003.
16. Kim YM, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. Association of atrial nicotinamide adenine dinucleotide phosphate oxidase activity with the development of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008;51:68-74.
17. Kaireviciute D, Blann AD, Balakrishnan B, Lane DA, Patel JV, Uzdavinys G et al. Characterisation and validity of inflammatory biomarkers in the prediction of post-operative atrial fibrillation in coronary artery disease patients. Thromb Haemost 2010;104:122-7.
18. Kourliouros A, Karastergiou K, Nowell J, Gukop P, Tavakkoli Hosseini M, Valencia O et al. Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery. Eur J Cardiothorac Surg 2011;39:228-32.
19. Wu ZK, Laurikka J, Vikman S, Nieminen R, Moilanen E, Tarkka MR. High postoperative interleukin-8 levels related to atrial fibrillation in patients undergoing coronary artery bypass surgery. World J Surg 2008;32:2643-9.
20. Gibson PH, Cuthbertson BH, Croal BL, Rae D, El-Shafei H, Gibson G et al. Usefulness of neutrophil/lymphocyte ratio as predictor of new-onset atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 2010;105:186-91.
21. Lamm G, Auer J, Weber T, Berent R, Ng C, Eber B. Postoperative white blood cell count predicts atrial fibrillation after cardiac surgery. J Cardiothorac Vasc Anesth 2006;20:51-6.
22. Abdelhadi RH, Gurm HS, Van Wagoner DR, Chung MK. Relation of an exaggerated rise in white blood cells after coronary bypass or cardiac valve surgery to development of atrial fibrillation postoperatively. Am J Cardiol 2004;93:1176-8.
23. Ramlawi B, Otu H, Mieno S, Boodhwani M, Sodha NR, Clements RT et al. Oxidative stress and atrial fibrillation after cardiac surgery: a case-control study. Ann Thorac Surg 2007;84:1166-73.
24. Karimi A, Bidhendi LM, Rezvanfard M, Bina P, Yousefi A, Molai M et al. The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2012;94:8-14.
25. Folkeringa RJ, Tieleman RG, Maessen JG, Prins MH, Nieuwlaat R, Crijns HJGM. Statins do not reduce atrial fibrillation after cardiac valvular surgery: a single centre observational study. Netherlands Heart J 2011;19:17-23.
26. Paturi A, Shukla A, Ebra G, Nguyen V, Borzak S. Do statins reduce atrial fibrillation after coronary artery bypass grafting? J Atr Fibrillation 2011;2:6.
27. Rader F, Gajulapalli RD, Pasala T, Einstadter D. Effect of early statin therapy on risk of atrial fibrillation after coronary artery bypass grafting with or without concomitant valve surgery. Am J Cardiol 2011;108:220-2.
28. Sakamoto H, Watanabe Y, Satou M. Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Ann of Thorac Cardiovasc Surg 2011;4:376-82.
29. Alves RJ, Campos RN, Nakiri K. Chronic and regular use of statin prevents atrial fibrillation in period after cardiac surgery. Arq Bras Cardiol 2010;95:614-20.
30. Kinoshita T, Asai T, Nishimura O, Hiramatsu N, Suzuki T, Kambara A et al. Statin for prevention of atrial fibrillation after off-pump coronary artery bypass grafting in Japanese patients. Circ J 2010;74:1846-51.
31. Tamura K, Arai H, Ito F, Someya T, Ushiyama T, Miyagi N. Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation. Gen Thorac Cardiovasc Surg 2010;58:120-5.
32. Miceli A, Fino C, Fiorani B, Yeatman M, Narayan P, Angelini GD et al. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg 2009;87:1853-8.
33. Kourliouros A, De Souza A, Roberts N, Marciniak A, Tsiouris A, Valencia O et al. Dose-related effect of statins on atrial fibrillation after cardiac surgery. Ann Thorac Surg 2008;85:1515-20.
34. Subramaniam K, Koch CG, Bashour A, O'Connor M, Xu M, Gillinov AM et al. Preoperative statin intake and morbid events after isolated coronary artery bypass grafting. J Clin Anesth 2008;1:4-11.
35. Virani SS, Nambi V, Razavi M, Lee VV, Elayda M, Wilson JM et al. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J 2008;155:541-6.
36. Mariscalco G, Lorusso R, Klersy C, Ferrarese S, Tozzi M, Vanoli D et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg 2007;84:1158-64.
37. Ozaydin M, Dogan A, Varol E, Kapan S, Tuzun N, Peker O et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology 2007;107:117-21.
38. Marin F, Pascual DA, Roldan V, Arribas JM, Ahumada M, Tornel PL et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol 2006;97:55-60.
39. Ibrahim TM, Hill PC, Bafi AS, Kanda LT, Ellis JL, Lowery RC et al. The effect of vitamin C on the incidence of atrial fibrillation after major cardiac surgery. Chest 2010;138:4.
40. Carnes CA, Chung MK, Nakayama T, Nakayama H, Baliga RS, Piao S et al. Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res 2001;89:E32-8.
41. Ruffin RT, Kluger J, Baker WL, Wills SM, White CM, Coleman CI. Association between perioperative NSAID use and post-cardiothoracic surgery atrial fibrillation, blood transfusions, and cardiovascular outcomes: a nested cohort study from the AF suppression trials (AFIST) I, II and III. Cur Med Res Opin 2008;24:1131-6.
42. Kourliouros A, Valencia O, Hosseini MT, Mayr M, Sarsam M, Camm J et al. Preoperative high-dose atorvastatin for prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. J Thorac Cardiovasc Surg 2011;141:244-8.
43. Sun Y, Ji Q, Mei Y, Wang X, Feng J, Cai J et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J 2011;52:7-11.
44. Ji Q, Mei Y, Wang X, Sun Y, Feng J, Cai J et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J 2009;73:2244-9.
45. Lertsburapa K, White CM, Kluger J, Faheem O, Hammond J, Coleman CI. Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg 2008;135:405-11.
46. Song YB, On YK, Kim JH, Shin DH, Kim JS, Sung J et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J 2008;156:373.e9-16.
47. Patti G, Chello M, Candura D, Pasceri V, D'Ambrosio A, Covino E et al. Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of MYocardial Dysrhythmia After cardiac surgery) study. Circulation 2006;114:1455-61.
48. Bjordahl PM, Helmer SD, Gosnell DJ, Wemmer GE, O'Hara WW, Milfeld DJ. Perioperative supplementation with ascorbic acid does not prevent atrial fibrillation in coronary artery bypass graft patients. Am J Surg 2012;204:862-7.
49. Rodrigo R, Gutiérrez R, Fernández R, Guzmán P. Ageing improves the antioxidant response against postoperative atrial fibrillation: a randomized controlled trial. Interact Cardiovasc Thorac Surg 2012;15:209-14.
50. Farquharson AL, Metcalf RG, Sanders P, Stuklis R, Edwards JR, Gibson RA et al. Effect of dietary fish oil on atrial fibrillation after cardiac surgery. Am J Cardiol 2011;108:851-6.
51. Papoulidis P, Ananiadou O, Chalvatzoulis E, Ampatzidou F, Koutsogiannidis C, Karaiskos T et al. The role of ascorbic acid in the prevention of atrial fibrillation after elective on-pump myocardial revascularization surgery: a single-center experience - a pilot study. Interact Cardiovasc Thorac Surg 2011;12:121-4.
52. Eslami M, Badkoubeh RS, Mousavi M, Radmehr H, Salehi M, Tavakoli N et al. Oral ascorbic acid in combination with beta-blockers is more effective than beta-blockers alone in the prevention of atrial fibrillation after coronary artery bypass grafting. Tex Heart Inst J 2007;34:268-74.
53. Imazio M, Brucato A, Ferrazzi P, Rovere ME, Gandino A, Cemin R et al. Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy. Circulation 2011;124:2290-5.
54. Horbach SJ, Lopes RD, da C Guaragna JC, Martini F, Mehta RH, Petracco JB et al. Naproxen as prophylaxis against atrial fibrillation after cardiac surgery: the NAFARM randomized trial. Am J Med 2011;124:1036-42.
55. Cheruku KK, Ghani A, Ahmad F, Pappas P, Silverman PR, Zelinger A et al. Efficacy of nonsteroidal anti-inflammatory medications for the prevention of atrial fibrillation following coronary artery bypass graft surgery. Prev Cardiol 2004;7:13-8.
56. Ozaydin M, Peker O, Erdogan D, Kapan S, Turker Y, Varol E et al. N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study. Eur Heart J 2008;29:625-31.
57. El-Hamamsy I, Stevens LM, Carrier M, Pellerin M, Bouchard D, Demers P et al. Effect of intravenous N-acetylcysteine on outcomes after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2007;133:7-12.
58. Haase M, Haase-Fielitz A, Bagshaw SM, Reade MC, Morgera S, Seevenayagam S et al. Phase II, randomized, controlled trial of high-dose N-acetylcysteine in high-risk cardiac surgery patients. Crit Care Med 2007;35:1324-31.
59. Wijeysundera DN, Beattie WS, Rao V, Granton JT, Chan CT. N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with preexisting moderate renal insufficiency. Can J Anaesth 2007;54:872-81.
60. Abbaszadeh M, Khan ZH, Mehrani F, Jahanmehr H. Perioperative intravenous corticosteroids reduce incidence of atrial fibrillation following cardiac surgery: a randomized study. Rev Bras Cir Cardiovasc 2012;27:18-23.
61. Halonen J, Halonen P, Jarvinen O, Taskinen P, Auvinen T, Tarkka M et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 2007;297:1562-7.
62. Yared JP, Bakri MH, Erzurum SC, Moravec CS, Laskowski DM, Van Wagoner DR et al. Effect of dexamethasone on atrial fibrillation after cardiac surgery: prospective, randomized, double-blind, placebo-controlled trial. J Cardiothorac Vasc Anesth 2007;21:68-75.
63. Prasongsukarn K, Abel JG, Jamieson RE, Cheung A, Russell JA, Walley KR et al. The effects of steroids on the occurrence of postoperative atrial fibrillation after coronary artery bypass grafting surgery: a prospective randomized trial. J Thorac Cardiovasc Surg 2005;130:93-8.
64. Halvorsen P, Raeder J, White PF, Almdahl SM, Nordstrand K, Saatvedt K et al. The effect of dexamethasone on side effects after coronary revascularization procedures. Anesth Analg 2003;96:1578-83.
65. Yared JP, Starr NJ, Torres FK, Bashour CA, Bourdakos G, Piedmonte M et al. Effects of single dose, postinduction dexamethasone on recovery after cardiac surgery. Ann Thorac Surg 2000;69:1420-4.
66. Liakopoulos OJ, Kuhn EW, Slottosch I, Wassmer G, Wahlers T. Preoperative statin therapy for patients undergoing cardiac surgery. Cochrane Database Syst Rev 2012;4:CD008493.
67. Chello M, Anselmi A, Spadaccio C, Patti G, Goffredo C, Di Sciascio G et al. Simvastatin increases neutrophil apoptosis and reduces inflammatory reaction after coronary surgery. Ann Thorac Surg 2007;83:1374-80.
68. Gu WJ, Wu ZJ, Wang PF, Aung LH, Yin RX. N-Acetylcysteine supplementation for the prevention of atrial fibrillation after cardiac surgery: a meta-analysis of eight randomized controlled trials. BMC Cardiovasc Disord 2012;12:10.
69. Harling L, Rasoli S, Vecht JA, Ashrafian H, Kourliouros A, Athanasiou T. Do antioxidant vitamins have an anti-arrhythmic effect following cardiac surgery? A meta-analysis of randomised controlled trials. Heart 2011;97:1636-42.
70. Whitlock RP, Chan S, Devereaux PJ, Sun J, Rubens FD, Thorlund K et al. Clinical benefit of steroid use in patients undergoing cardiopulmonary bypass: a meta-analysis of randomized trials. Eur Heart J 2008;29:2592-600.